Clinical Trial Update: Ocular Tissue Levels of 1.5% Levofloxacin Ophthalmic Solution Compared to an Active Comparator [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ocular tissue levels of 1.5% levofloxacin ophthalmic solution to an active comparator in cataract patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Levofloxacin Ophthalmic Solution 1.5% (levofloxacin)

Snippet

Sponsor: Santen Inc. | Conditions: Cataract | Phase 4 | Status: COMPLETED